BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18684792)

  • 1. Quality of life and inflammation in exacerbations of bronchiectasis.
    Courtney JM; Kelly MG; Watt A; Garske L; Bradley J; Ennis M; Elborn JS
    Chron Respir Dis; 2008; 5(3):161-8. PubMed ID: 18684792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis.
    Guran T; Ersu R; Karadag B; Karakoc F; Demirel GY; Hekim N; Dagli E
    J Clin Pharm Ther; 2008 Dec; 33(6):603-11. PubMed ID: 19138237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammation markers in the exhaled air of patients with bronchiectasis unassociated with cystic fibrosis].
    Palop-Cervera M; de Diego Damiá A; Martínez-Moragón E; Cortijo J; Fullana J; León M
    Arch Bronconeumol; 2009 Dec; 45(12):597-602. PubMed ID: 19875219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis.
    Guran T; Ersu R; Karadag B; Akpinar IN; Demirel GY; Hekim N; Dagli E
    Pediatr Pulmonol; 2007 Apr; 42(4):362-9. PubMed ID: 17351928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
    Nicolson CH; Stirling RG; Borg BM; Button BM; Wilson JW; Holland AE
    Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in health status following bronchopulmonary hygiene physical therapy in patients with bronchiectasis.
    Mutalithas K; Watkin G; Willig B; Wardlaw A; Pavord ID; Birring SS
    Respir Med; 2008 Aug; 102(8):1140-4. PubMed ID: 18585027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of patients with purulent bronchiectasis to antibiotics for four months.
    Hill SL; Burnett D; Hewetson KA; Stockley RA
    Q J Med; 1988 Feb; 66(250):163-73. PubMed ID: 3262882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
    Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.
    Yalçin E; Kiper N; Ozçelik U; Doğru D; Firat P; Sahin A; Ariyürek M; Mocan G; Gürcan N; Göçmen A
    J Clin Pharm Ther; 2006 Feb; 31(1):49-55. PubMed ID: 16476120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis.
    Mandal P; Sidhu MK; Donaldson LS; Chalmers JD; Smith MP; Turnbull K; Scott J; Hill AT
    QJM; 2013 Jan; 106(1):27-33. PubMed ID: 23019590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations.
    Newport S; Amin N; Dozor AJ
    Pediatr Pulmonol; 2009 Sep; 44(9):866-72. PubMed ID: 19670404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis.
    Lin HC; Cheng HF; Wang CH; Liu CY; Yu CT; Kuo HP
    Am J Respir Crit Care Med; 1997 Jun; 155(6):2024-9. PubMed ID: 9196111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acapella versus 'usual airway clearance' during acute exacerbation in bronchiectasis: a randomized crossover trial.
    Patterson JE; Hewitt O; Kent L; Bradbury I; Elborn JS; Bradley JM
    Chron Respir Dis; 2007; 4(2):67-74. PubMed ID: 17621572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations.
    Kodric M; Garuti G; Colomban M; Russi B; Porta RD; Lusuardi M; Confalonieri M
    Respirology; 2009 Apr; 14(3):424-8. PubMed ID: 19192230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma.
    Booker R; Olson K; Pilarski LM; Noon JP; Bahlis NJ
    Oncol Nurs Forum; 2009 Mar; 36(2):209-16. PubMed ID: 19273410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of azithromycin in the treatment of bronchiectasis.
    Lourdesamy Anthony AI; Muthukumaru U
    Respirology; 2014 Nov; 19(8):1178-82. PubMed ID: 25183304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
    Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in quality of life, physical activity, and symptomatic status one year after myocardial revascularization for stable angina.
    Markou AL; van der Windt A; van Swieten HA; Noyez L
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1009-15. PubMed ID: 18778947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.